CVRdatabase
Menu

Pharmacosmos A/S

Public limited companyCVR 15517085HolbækActive

Pharmacosmos A/S is a public limited company, based in Holbæk, active in manufacture of pharmaceutical preparations, founded in 1991. Net profit fell 56% from 2025 to 2026, ending at DKK 714m. Measured by gross profit, it ranks no. 6 of 57 companies in the industry in the database. With 328 employees, the company is about 33 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2026

RevenueDKK 2.2bn−17% vs. 2025
Net profitDKK 714m−56% vs. 2025
EquityDKK 2.8bn+26.3% vs. 2025
Employees328latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit fell 25% (2025 → 2026), to DKK 1.6bn.
  • Revenue fell 17% (2025 → 2026), to DKK 2.2bn.
  • Net profit fell 56% (2025 → 2026), to DKK 714m.
  • Equity rose 26% (2025 → 2026), to DKK 2.8bn.

Employees

  • 50 more employees than a year earlier: 328 (08/2026) against 278 (08/2025).

Management and owners, last 24 months

  • New in management: Claes Christian Strøm (director, 18/09/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

−DKK 500mDKK 0DKK 500mDKK 1bnDKK 1.5bnDKK 2bnDKK 2.5bnDKK 3bn202120222023202420252026
EquityNet profit
Financial figures for Pharmacosmos A/S
202120222023202420252026Change
Revenue849,3411,321,4871,104,1661,613,1412,623,0002,176,000−17%
Gross profit526,421942,439674,1351,245,3632,093,0001,577,000−24.7%
Operating profit (EBIT)−71,421124,286272,231679,5252,359,000838,000−64.5%
Profit before tax−150,156202,845165,9161,038,9112,225,000886,000−60.2%
Net profit−136,005170,038114,274789,7011,622,000714,000−56%
Total assets1,544,2931,721,3491,753,4502,657,6954,723,0004,544,000−3.8%
Equity642,802807,467854,5941,635,7842,197,0002,775,000+26.3%
Liabilities857,661903,821891,7951,021,911–––
Cash and cash equivalents699,872508,984426,999103,519205,000650,000+217.1%
Average number of employees352468191208240286+19.2%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 500mDKK 1bnDKK 1.5bnDKK 2bn202120222023202420252026
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2026 figures

  • Profit for five years in a row

    Net result has been positive in 2022–2026.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Pharmacosmos A/S
Financial yearPeriodPublishedFigures forDocuments
202601/05/2025 – 30/04/202608/07/2026The companyPDF not statedXBRL
202501/05/2024 – 30/04/202509/07/2025The companyPDF not statedXBRL
202401/05/2023 – 30/04/202413/07/2024The companyPDFXBRL
202301/05/2022 – 30/04/202314/07/2023The companyPDFXBRL
202201/05/2021 – 30/04/202213/07/2022The groupPDFXBRL
202101/05/2020 – 30/04/202118/08/2021The groupPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05010015020025030035009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 1.6bnNo. 6 of 57
Better than 91% of the companies in the industry
EquityDKK 2.8bnNo. 8 of 59
Better than 88% of the companies in the industry
Number of employees328No. 11 of 59
Better than 83% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 200–499 employees796 companies in the comparison
No. 11of 763
Better than 99%
No. 20of 796
Better than 98%
Companies that are at least 30 years old10,276 companies in the comparison
No. 54of 10,152
Better than 99%
No. 93of 10,275
Better than 99%
All companies of type A/S18,025 companies in the comparison
No. 86of 17,786
Better than 100%
No. 175of 18,024
Better than 99%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Pharmacosmos A/SDKK 1.6bn
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Pharmacosmos A/SDKK 714m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Pharmacosmos A/SDKK 2.8bn
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Pharmacosmos A/S328
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Pharmacosmos Holding A/S100%
Pharmacosmos A/S

Management

8 active registrations

Executive management

Executive management at Pharmacosmos A/S
NameRoleAppointed
Tobias Sidelmann ChristensenCEO28/06/2022
Henrik ParkerDirector08/12/2023
Claes Christian StrømDirector18/09/2025

Board of directors

Board of directors at Pharmacosmos A/S
NameRoleAppointed
Lars ChristensenBoard member01/10/1991
Jacob TolstrupChair of the board08/02/2019
Martin Holst LangeBoard member15/08/2023
Milena Jordanova OlsenBoard member27/06/2024
Lars GreenBoard member27/06/2024
Founders
VX 10.312 ApS, Medimex ApS, ApS Kbil 9 Nr. 1008
Former management (14)
Former management at Pharmacosmos A/S
NameRoleAppointedResigned
Ulf Svejgaard PoulsenBoard member01/10/199103/02/1992
Susanne Saul StakemannChair of the board01/10/199103/02/1992
Per Emil Hasselbalch StakemannBoard member01/10/199103/02/1992
Per Emil Hasselbalch StakemannDirector01/10/199103/02/1992
Henry Marinus ChristensenChair of the board01/10/199109/02/1996
Henry Marinus ChristensenDirector01/10/199115/12/1994
Torkil ChristensenBoard member01/10/199114/10/1994
Annemarie SidelmannChair of the board01/10/199123/04/2002
Lars Juul PeitersenBoard member01/10/199123/04/2002
Axel KierkegaardChair of the board23/04/200208/02/2019
Tommy PedersenBoard member23/04/200227/06/2024
Lars ChristensenCEO01/02/200628/06/2022
Odd Inge Vaage-NilsenDirector01/02/200619/05/2010
Robert GuglielmettiDirector13/04/201108/12/2023

Signing rule: Selskabet tegnes af den samlede bestyrelse, eller af et medlem af direktionen og et medlem af bestyrelsen i forening, eller af Tobias Sidelmann Christensen.

Address and production units

1 active production units

Rørvangsvej 30
4300 Holbæk

Holbæk Municipality · Postcode 4300

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
PHARMACOSMOS A/SRørvangsvej 30, 4300 Holbæk3281008874391

Purpose

Selskabets formål er at drive fabrikation og virksomhed i forbindelse hermed

The purpose is quoted from the register in Danish.

Changes year by year

57 registered events
20261 changeaccounts 1
  • Annual report for 2026 published
20252 changesmanagement 1 · accounts 1
  • Claes Christian Strøm appointed director
  • Annual report for 2025 published
20244 changesaccounts 1 · management 3
  • Annual report for 2024 published
  • Lars Green appointed board member
  • Milena Jordanova Olsen appointed board member
  • Tommy Pedersen stepped down as board member
20234 changesmanagement 3 · accounts 1
  • Henrik Parker appointed director
  • Robert Guglielmetti stepped down as director
  • Martin Holst Lange appointed board member
  • Annual report for 2023 published
20223 changesaccounts 1 · management 2
  • Annual report for 2022 published
  • Tobias Sidelmann Christensen appointed ceo
  • Lars Christensen stepped down as ceo
20211 changeaccounts 1
  • Annual report for 2021 published
20192 changesmanagement 2
  • Jacob Tolstrup appointed chair of the board
  • Axel Kierkegaard stepped down as chair of the board
20111 changemanagement 1
  • Robert Guglielmetti appointed director
20101 changemanagement 1
  • Odd Inge Vaage-Nilsen stepped down as director
20081 changeindustry 1
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20071 changeaddress 1
  • Moved to Rørvangsvej 30, 4300 Holbæk
20062 changesmanagement 2
  • Lars Christensen appointed ceo
  • Odd Inge Vaage-Nilsen appointed director
20055 changesindustry 1 · name 1 · capital 1 · ownership 1 · merger 1
  • Industry changed to Aluminium production (244200)
  • Name changed from PHARMACOSMOS PHARMACEUTICALS A/S to PHARMACOSMOS A/S
  • Share capital changed from 100,000,000 DKK to 101,000,000 DKK
  • PHARMACOSMOS HOLDING A/S registered as owner (100%)
  • Merger registered in CVR
20041 changeaddress 1
  • Moved to Rørvangsvej 30, 4300 Holbæk
20031 changecapital 1
  • Share capital changed from 75,000,000 DKK to 100,000,000 DKK
20024 changesmanagement 4
  • Tommy Pedersen appointed board member
  • Axel Kierkegaard appointed chair of the board
  • Lars Juul Peitersen stepped down as board member
  • Annemarie Sidelmann stepped down as chair of the board
20003 changesname 1 · capital 2
  • Name changed from SOLOCHEM A/S to PHARMACOSMOS PHARMACEUTICALS A/S
  • Share capital changed from 25,000,000 DKK to 75,000,000 DKK
  • Share capital changed from 1,000,000 DKK to 25,000,000 DKK
19961 changemanagement 1
  • Henry Marinus Christensen stepped down as chair of the board
19942 changesmanagement 2
  • Henry Marinus Christensen stepped down as director
  • Torkil Christensen stepped down as board member
19926 changescapital 1 · name 1 · management 4
  • Share capital changed from 300,000 DKK to 1,000,000 DKK
  • Name changed from A/S PSE NR. 4442 to SOLOCHEM A/S
  • Susanne Saul Stakemann stepped down as chair of the board
  • Per Emil Hasselbalch Stakemann stepped down as director
  • Per Emil Hasselbalch Stakemann stepped down as board member
  • Ulf Svejgaard Poulsen stepped down as board member
199111 changesfounded 1 · management 10
  • Registered as A/S PSE NR. 4442
  • Susanne Saul Stakemann appointed chair of the board
  • Lars Juul Peitersen appointed board member
  • Lars Christensen appointed board member
  • Annemarie Sidelmann appointed chair of the board
  • Torkil Christensen appointed board member
  • Henry Marinus Christensen appointed director
  • Henry Marinus Christensen appointed chair of the board
  • Per Emil Hasselbalch Stakemann appointed director
  • Per Emil Hasselbalch Stakemann appointed board member
  • Ulf Svejgaard Poulsen appointed board member

Related companies

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026.

View in CVRReport a correction